TPOXX
| Chemical Name | tecovirimat |
| Dosage Form | Capsule (oral; 200 mg) |
| Drug Class | Antivirals |
| System | Skin, Blood, Respiratory |
| Company | Siga Technologies |
| Approval Year | 2018 |
Indication
- TPOXX is indicated for the treatment of human smallpox disease in adults and pediatric patients weighing at least 13 kg.